ReviewResearch and reports in urology2014

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability.

Hee Ju Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.